देश: कनाडा
भाषा: अंग्रेज़ी
स्रोत: Health Canada
LINEZOLID
AURO PHARMA INC
J01XX08
LINEZOLID
600MG
SOLUTION
LINEZOLID 600MG
INTRAVENOUS
300ML
Prescription
OXAZOLIDINONES
Active ingredient group (AIG) number: 0143501003; AHFS:
APPROVED
2017-10-26
LINEZOLID INJECTION PRODUCT MONOGRAPH PAGE 1 OF 44 PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PR LINEZOLID INJECTION Solution, 2 mg / mL, for intravenous infusion Antibacterial Agent Auro Pharma Inc. 3700 Steeles Avenue West, Suite # 402 Woodbridge, Ontario, L4L 8K8, Canada. Date of Initial Authorization: April 2, 2001 Date of Revision: January 16, 2023 Submission Control Number: 267159 LINEZOLID INJECTION PRODUCT MONOGRAPH PAGE 2 OF 44 RECENT MAJOR LABEL CHANGES 7 Warnings and Precautions, 7.1.2 Breastfeeding 01/2023 7 Warning and Precautions, 7.1.5 Patients with Phenylketonuria 01/2023 7 Warning and Precautions, Renal 01/2023 8 Adverse Reactions, 8.5 Post-Market Adverse Reactions 01/2023 4 Dosage and Administration, 4.1 Dosing Considerations 01/2023 7 Warnings and Precautions, Hematologic/Hepatic/Renal 01/2023 7 Warnings and Precautions, Monitoring and Laboratory Tests 01/2023 8 Adverse Reactions, 8.5 Post-Market Adverse Reactions 01/2023 TABLE OF CONTENTS SECTIONS OR SUBSECTIONS THAT ARE NOT APPLICABLE AT THE TIME OF AUTHORIZATION ARE NOT LISTED. RECENT MAJOR LABEL CHANGES ............................................................................................. 2 TABLE OF CONTENTS ............................................................................................................... 2 PART I: HEALTH PROFESSIONAL INFORMATION ...................................................................... 4 1 INDICATIONS ........................................................................................................................ 4 1.1 Pediatrics .................................................................................................................. 5 1.2 Geriatrics .................................................................................................................. 5 2 CONTRAINDICATIONS .......................................................................................................... 5 4 DOSAGE AND ADMINISTRATION ........................................ पूरा दस्तावेज़ पढ़ें